abstract |
The invention relates to novel compounds of formula (I) wherein R, R?1 and R2¿ have the designation cited in patent claim 1. Said compounds are inhibitors of the coagulation factors Xa and VIIa, and can be used to treat thromboses, myocardial infarction, arteriosclerosis, inflammation, apoplexy, angina pectoris, restenosis after angioplasty, intermittent claudication, tumours, tumour diseases and/or tumour metastases. |